Skip to main content
. 2022 Jun 23;79(7):377. doi: 10.1007/s00018-022-04364-5

Fig. 1.

Fig. 1

Development and genetic analysis of a highly brain-metastatic melanoma cell line model. A General workflow for the generation and enrichment of highly metastatic melanoma cell line clonal variants 2A and 2B from parental cell line YUGEN8. B Highly pigmented brain sample isolated from mice injected with Cl.2A tumor cells later confirmed by H&E staining. C Kaplan–Meier survival of nude mice following left ventricle injection of Cl.2A, Cl.2B, and Cl.1A cells (p < 0.0013, n = 31). D Tumor growth rates of Cl.1A, Cl.2A, and Cl.2B cells were implanted subcutaneously in athymic nude mice and monitored for 5 weeks (p > 0.05 and n = 18 for the three groups). Tumor growth was measured at study endpoint and tumor volumes shown were calculated using the ellipsoid volume formula. Scatter plots showing the correlation between the gene expression profiles of Cl.2A vs Cl.2B (E), Cl.1A vs Cl.2A (F), and Cl.1A vs Cl.2B (G), respectively. Fold changes of genes that encode for different ECM proteins overexpressed in both Cl.2A and Cl.2B vs parental YUGEN8 (H) and the metastatic indolent Cl.1A (I), respectively